Clovis Oncology Inc. Stock
Your prediction
Clovis Oncology Inc. Stock
Our community identified positive and negative aspects for Clovis Oncology Inc. stock for the coming years. 2 users see the criterium "Shareholder structure" as a plus for the Clovis Oncology Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Clovis Oncology Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clovis Oncology Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Clovis Oncology Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 1.880% | 12.739% | 1.659% | -50.864% | -28.501% | -67.883% | -94.618% |
| Evolus Inc | -0.520% | 7.961% | -10.945% | -55.318% | -29.083% | -48.467% | -57.056% |
| Sangamo Therapeutics Inc. | 0.510% | 1.388% | -29.790% | -61.259% | -33.162% | -84.467% | -97.559% |
